Literature DB >> 2958540

Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.

P J Wettstein1, M P Colombo.   

Abstract

The immunization of C57BL/6 responder mice with spleen cells from H-2-matched BALB.B donors, which differ by multiple non-H-2 histocompatibility (H) antigens, results in the generation of cytotoxic T lymphocytes (CTL) that are specific for only a limited number of immunodominant antigens. Previous analysis of the genes encoding these dominant antigens has not mapped these genes to any of the non-H-2 H loci defined by congenic strains. It would have been expected that the histogenetic techniques employed for congenic strain selection would have preferentially identified the "strongest" H antigens. Therefore, we have investigated the possibility that immunodominant antigens do not belong to the class of non-H-2 H antigens encoded by genes mapping to H loci defined and mapped by congenic strains. The first experiments were aimed at identifying antigens that were expressed by independently derived inbred strains and were cross-reactive with the immunodominant cytotoxic T cell target (CTT-1) antigen of BALB.B. Strong cross-reaction with the C3H.SW (H-2b) strain was observed; the C3H gene encoding this antigen was mapped with BXH recombinant inbred strains. Contrary to the mapping of the CTT-1 gene to chromosome 1 in BALB.B, the C3H gene was shown to map to either chromosome 4 or chromosome 7. This result indicates that identical, or at least extensively cross-reactive, non-H-2 antigens may be encoded by genes mapping to independently segregating loci in different inbred strains. The tissue distribution of immunodominant antigens was approached by determining the reactivity of CTL specific for these antigens with either lymphoid-derived or fibroblast-derived targets. These CTL effectively lysed lymphoblast and lymphoid tumor targets but did not lyse an SV40-transformed fibroblast line that was shown to be efficiently lysed by CTL specific for non-H-2 H antigens defined by congenic strains. Therefore, it was concluded that immunodominant antigens detected by B6 anti-BALB.B CTL have a restricted tissue distribution in comparison to non-H-2 H antigens defined by congenic strains. The implications of these results for our understanding of the origin and heterogeneity of non-H-2 cell-surface antigen recognized by effector T cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958540

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice.

Authors:  A Juretic; B B Knowles
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. V. Chromosomal mapping of the immunodominant cytotoxic T-cell target-1 (CTT-1).

Authors:  M Vagliani; C Melani; G Parmiani; P D'Eustachio; P J Wettstein; M P Colombo
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR.

Authors:  I Miconnet; V de la Selle; C Tucek; R Huchet; D Bonardelle; M Bruley-Rosset
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.

Authors:  Jean Kwun; Subramaniam Malarkannan; William J Burlingham; Stuart J Knechtle
Journal:  J Immunol       Date:  2011-09-07       Impact factor: 5.422

5.  Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.

Authors:  S Shenoy; K Desch; B Duffy; P Thorson; T Mohanakumar
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

6.  SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice.

Authors:  P J Wettstein; L Jewett; S Faas; R L Brinster; B B Knowles
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

7.  Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice.

Authors:  M Bruley Rosset; V Tieng; D Charron; A Toubert
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

8.  Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.

Authors:  Kang Il Yoo; Ji Yeong Jeon; Su Jeong Ryu; Giri Nam; Hyewon Youn; Eun Young Choi
Journal:  Exp Mol Med       Date:  2015-02-13       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.